Results
|
1.
|
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. MedStar authors:
Year: 2021
Citation: - JAMA Surgery. 156(3):e206363, 2021 03 01.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baratti D, Barretta F, Barrios P, Ceelen W, de Hingh I, Deraco M, Glehen O, Goere D, Gomez-Portilla A, Gonzalez-Moreno S, Kusamura S, Levine EA, Moran BJ, Morris DL, Nizri E, Pelz JOW, Peritoneal Surface Oncology Group International (PSOGI) and the French National Registry of Rare Peritoneal Surface Malignancies (RENAPE), Piso P, Quenet F, Sardi A, Sugarbaker PH, Van Der Speeten K, Villeneuve L, Yonemura Y
|
|
2.
|
|
|
3.
|
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. MedStar authors:
- Sugarbaker, Paul H
- Yan, Tristan D
Year: 2012
Citation: - Journal of Clinical Oncology. 30(20):2449-56, 2012 Jul 10.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Baratti D, Barrios P, Ceelen WP, Chua TC, de Hingh IH, Deraco M, Elias D, Gilly FN, Glehen O, Gomez Portilla A, Gonzalez-Moreno S, Levine EA, Liauw W, Moran BJ, Morris DL, Pelz JO, Piso P, Sardi A, Sugarbaker PH, Van Der Speeten K, Yan TD
|